Efficacy of MUCIPLIQ on the Incidence of Radio-chemotherapy-induced Mucositis in Patients Suffering From Oral Cancer [clinicaltrials:NCT01840436]

Bio2RDF uri

Efficacy of MUCIPLIQ on the Incidence of Radio-chemotherapy-induced Mucositis in Patients Suffering From Oral Cancer [clinicaltrials:NCT01840436]

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

http://bio2rdf.org/clinicaltrials:NCT01840436

Bio2RDF identifier

NCT01840436

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT01840436

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT01840436

acronym [clinicaltrials_vocabulary:acronym]

MUCIPLIQ

http://www.w3.org/2001/XMLSchema#string

anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]

105

http://www.w3.org/2001/XMLSchema#integer

arm group [clinicaltrials_vocabulary:arm-group]

NCT01840436 arm group 6f8ce038bc50a5372fcaf86e4b300bb6 [clinicaltrials_resource:NCT01840436/arm-group/6f8ce038bc50a5372fcaf86e4b300bb6]

NCT01840436 arm group 7e66811d599ca65fad26f5bf3d377dd6 [clinicaltrials_resource:NCT01840436/arm-group/7e66811d599ca65fad26f5bf3d377dd6]

NCT01840436 arm group c8e70379bc98247aed803b0f8974257d [clinicaltrials_resource:NCT01840436/arm-group/c8e70379bc98247aed803b0f8974257d]

authority [clinicaltrials_vocabulary:authority]

clinicaltrials_resource:2775b5a5fcab71a5c18ad01a4f2afdd6

brief summary [clinicaltrials_vocabulary:brief-summary]

MUCIPLIQ is a nanopolym ...... therapy and radiations.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Efficacy of MUCIPLIQ on the In ...... nts Suffering From Oral Cancer

http://www.w3.org/2001/XMLSchema#string

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Incidence of grade 2 or higher oral mucositis Recruitment, 2, 3, 4, 5, 6, 7 and 11 to 13 weeks [clinicaltrials_resource:b6e7273ff3dec2d7ed07c23669fb63c4]

clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Incidence of grade 2 or higher oral mucositis Recruitment, 2, 3, 4, 5, 6, 7 and 11 to 13 weeks [clinicaltrials_resource:5233b2ac1c3eb2b83b111cd233ad04a0]

Incidence of grade 2 or higher oral mucositis Recruitment, 2, 3, 4, 5, 6, 7 and 11 to 13 weeks [clinicaltrials_resource:55455c40abde6313c5b4e3dcfc3edb7f]

Incidence of grade 2 or higher oral mucositis Recruitment, 2, 3, 4, 5, 6, 7 and 11 to 13 weeks [clinicaltrials_resource:6078d093aaad2754f1afbc08faa21e97]

Incidence of grade 2 or higher oral mucositis Recruitment, 2, 3, 4, 5, 6, 7 and 11 to 13 weeks [clinicaltrials_resource:9c08003b4e8838f2921f75bf541fde0e]

Incidence of grade 2 or higher oral mucositis Recruitment, 2, 3, 4, 5, 6, 7 and 11 to 13 weeks [clinicaltrials_resource:a04360140c073a7c22b0a79ae3d7a9ef]

completion date [clinicaltrials_vocabulary:completion-date]

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT01840436 [clinicaltrials_resource:45ca2d4269a9f093bc339a2fc704911d]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2013-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

MUCIPLIQ [clinicaltrials_resource:000c074bf5febc60cb14f1522c93eb60]

Placebo [clinicaltrials_resource:151141631e47efacee315dea041abae2]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

MUCIPLIQ

http://www.w3.org/2001/XMLSchema#string

Matrix therapy

http://www.w3.org/2001/XMLSchema#string

Oral mucositis

http://www.w3.org/2001/XMLSchema#string

RGTA

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2014-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Organ, Tissue, Regeneration, Repair and Replacement [clinicaltrials_resource:f3e56ce418c503a2f28c686dea7dc617]

location [clinicaltrials_vocabulary:location]

Centre Hospitalier Intercommunal de Créteil [clinicaltrials_resource:1057a33618096b837533d02e2bae7a85]

nct id [clinicaltrials_vocabulary:nct-id]

NCT01840436

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

A Randomized Controlled Study ...... Aerodigestive Tract Carcinomas

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

CT11M10MURT

http://www.w3.org/2001/XMLSchema#string

overall contact [clinicaltrials_vocabulary:overall-contact]

Nicolas Daly-Schveitzer, MD, PhD [clinicaltrials_resource:096fbdc425c652f8e13f396ae41c1a02]

overall contact backup [clinicaltrials_vocabulary:overall-contact-backup]

Nicolas Daly-Schveitzer, MD, PhD [clinicaltrials_resource:dc9bd2ebcca546b5be9caf58203da8a1]

overall official [clinicaltrials_vocabulary:overall-official]

Nicolas Daly-Schveitzer, MD, PhD [clinicaltrials_resource:63d6faa324e8f7fd005660d0780419cc]

overall status [clinicaltrials_vocabulary:overall-status]

Recruiting [clinicaltrials_resource:5231dee7156b84b0d1854de1a18dd169]

oversight [clinicaltrials_vocabulary:oversight]

France: Agence Nationale de Sécurité du Médicament et des produits de santé [clinicaltrials_resource:295149476da39ad659f8e61bfc4b0dc2]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

source [clinicaltrials_vocabulary:source]

Organ, Tissue, Regeneration, Repair and Replacement [clinicaltrials_resource:f3e56ce418c503a2f28c686dea7dc617]

start date [clinicaltrials_vocabulary:start-date]

2013-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT01840436 study design [clinicaltrials_resource:6713a797e516340c553904e75677f55e]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT01840436

verification date [clinicaltrials_vocabulary:verification-date]

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT01840436

http://www.w3.org/2001/XMLSchema#string

title

Efficacy of MUCIPLIQ on the In ...... nts Suffering From Oral Cancer

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Efficacy of MUCIPLIQ on the In ...... r [clinicaltrials:NCT01840436]

@en